Compare LGVN & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGVN | WKSP |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 7.0M |
| IPO Year | 2021 | 2015 |
| Metric | LGVN | WKSP |
|---|---|---|
| Price | $1.39 | $0.35 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $61.25 | N/A |
| AVG Volume (30 Days) | 151.7K | ★ 274.2K |
| Earning Date | 11-03-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.76 | 45.89 |
| EPS | ★ N/A | N/A |
| Revenue | $709,000.00 | ★ $16,101,738.00 |
| Revenue This Year | $46.15 | $124.82 |
| Revenue Next Year | $396.46 | $8.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 89.78 |
| 52 Week Low | $0.48 | $0.37 |
| 52 Week High | $7.60 | $3.48 |
| Indicator | LGVN | WKSP |
|---|---|---|
| Relative Strength Index (RSI) | 28.36 | 29.36 |
| Support Level | $0.60 | N/A |
| Resistance Level | $7.30 | $0.47 |
| Average True Range (ATR) | 0.21 | 0.03 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 0.69 | 5.60 |
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Worksport Ltd designs, develops, and manufactures products for markets including automotive accessories, consumer electronics, and residential and commercial HVAC systems. The company leverages a growing intellectual property portfolio of patents, designs, and trademarks covering products such as tonneau covers, solar-integrated tonneau covers, portable power stations, hydrogen-based green energy systems, heat pumps, and EV charging solutions. Its segments include soft tonneau covers, consisting mainly of vinyl-wrapped tri-fold and quad-fold covers manufactured by third-party suppliers, and hard tonneau covers, which generate the majority of revenue in the United States and include aluminum tri-fold and quad-fold covers manufactured and assembled in the United States.